{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:42:57Z","timestamp":1792341777792,"version":"4.4.0"},"reference-count":35,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Med Screen"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Self-sampling for high-risk human papillomavirus (hrHPV) testing has been introduced in cervical cancer screening programs to improve participation. In the Netherlands, women with an hrHPV-positive self-sample are required to visit their GP's office for cytology triage, as this cannot be performed on self-sampled material. Non-attendance at this step reduces screening effectiveness. This study examined whether sociodemographic and health-related behavioural factors commonly associated with screening participation are also associated with cytology triage attendance after an hrHPV-positive self-sample and whether these associations differ by age.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a study on the Lifelines cohort of participants in the Dutch cervical cancer screening program who used self-sampling between 2017 and 2024. The main outcome was cytology triage attendance within 6 months after an hrHPV-positive self-sample. Lifelines contains data on sociodemographic and behavioural factors including education, income, marital status, smoking, alcohol, diet, body mass index, physical activity, television viewing, sleep duration, lifetime use of hormonal contraception, parity, number of children and age at first childbirth. Logistic regression analyses were performed, including age-stratified models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among women with an hrHPV-positive self-sample, 10.2% did not attend cytology triage within 6 months. Most sociodemographic and lifestyle factors were not associated with cytology triage attendance, and no meaningful differences were observed between age groups. However, inadequate prior screening history was associated with lower odds of cytology triage attendance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The lack of associations with lifestyle or sociodemographic factors suggest that program-level strategies such as how hrHPV test results are communicated, might be more effective in increasing triage participation than interventions targeting specific subgroups.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09691413261498648","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T11:20:22Z","timestamp":1792149622000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Factors associated with cytology triage attendance after a hrHPV-positive self-sample and age-related differences: The lifelines cohort"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2344-7712","authenticated-orcid":false,"given":"Ekram S.","family":"Jemal","sequence":"first","affiliation":[{"name":"University of Groningen, University Medical Center Groningen","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6085-0678","authenticated-orcid":false,"given":"Albert G.","family":"Siebers","sequence":"additional","affiliation":[{"name":"Dutch Nationwide Pathology Databank","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3655-143X","authenticated-orcid":false,"given":"Ed","family":"Schuuring","sequence":"additional","affiliation":[{"name":"University of Groningen","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Bea A.","family":"Wisman","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3104-4471","authenticated-orcid":false,"given":"Geertruida H.","family":"De Bock","sequence":"additional","affiliation":[{"name":"University of Groningen, University Medical Center Groningen","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3257939"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2013.02.004"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.3390\/v9080229"},{"key":"e_1_3_3_6_2","unstructured":"WHO recommends DNA testing as a first-choice screening method for cervical cancer prevention [Internet]. [cited 2024 May 13]. Available from: https:\/\/www.who.int\/europe\/news\/item\/11-09-2021-who-recommends-dna-testing-as-a-first-choice-screening-method-for-cervical-cancer-prevention"},{"key":"e_1_3_3_7_2","volume-title":"WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. 2nd edition","author":"Introduction","year":"2021","unstructured":"Introduction. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention [Internet]. 2nd edition [Internet]. World Health Organization; 2021 [cited 2024 Apr 16]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572321\/"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30763-0"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2021.101328"},{"key":"e_1_3_3_10_2","unstructured":"Framework for the Execution of Cervical Cancer Population Screening | RIVM [Internet]. [cited 2024 Jun 10]. Available from: https:\/\/www.rivm.nl\/documenten\/framework-for-execution-of-cervical-cancer-population-screening"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.34902"},{"key":"e_1_3_3_12_2","unstructured":"Monitor cervical cancer screening 2024 | RIVM [Internet]. [cited 2026 Feb 25]. Available from: https:\/\/www.rivm.nl\/en\/documenten\/monitor-cervival-cancer-screening"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2026.101635"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01954-9"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1275354"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/08870446.2022.2050230"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106119"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-264"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-17293-0"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","unstructured":"Paolino M Gago J Pera AL et al. Adherence to triage among women with HPV-positive self-collection: a study in a middle-low income population in Argentina. E Cancermedicalscience 2020; 14: 1138. doi:10.3332\/ecancer.2020.1138 PubMed PMID: 33281930; PubMed Central PMCID: PMC7685770.","DOI":"10.3332\/ecancer.2020.1138"},{"key":"e_1_3_3_21_2","first-page":"2681","article-title":"HPV self-sampling or the pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France","volume":"133","author":"Sancho-Garnier H","year":"2013","unstructured":"Sancho-Garnier H, Tamalet C, Halfon P, et al. HPV self-sampling or the pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 2013; 133: 2681\u20132687.","journal-title":"Int J Cancer"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08601-z"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyu229"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/2007\/971816"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2015.07.006"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-22-0712"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2015.176"},{"key":"e_1_3_3_28_2","article-title":"Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results","volume":"58","author":"Elit L","year":"2012","unstructured":"Elit L, Krzyzanowska M, Saskin R, et al. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results. Can Fam Physician 2012; 58: e22\u2013e31. PubMed PMID: 22267636; PubMed Central PMCID: PMC3264035.","journal-title":"Can Fam Physician"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1353\/hpu.2019.0050"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2019-054290"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/LGT.0b013e31815d8d88"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-23532-3"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/21642850.2020.1798239"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289647"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1243888"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-023-01517-6"}],"container-title":["Journal of Medical Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413261498648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09691413261498648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09691413261498648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T16:18:36Z","timestamp":1792340316000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09691413261498648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":35,"alternative-id":["10.1177\/09691413261498648"],"URL":"https:\/\/doi.org\/10.1177\/09691413261498648","relation":{},"ISSN":["0969-1413","1475-5793"],"issn-type":[{"value":"0969-1413","type":"print"},{"value":"1475-5793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"article-number":"09691413261498648"}}